Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients

Digestive Diseases and Sciences

Volumn 48, Issue 4, 2003, Pages 802-808

  Giannini, Edoardo ^a   Fasoli, Alberto ^a   Botta, Federica ^a   Romagnoli, Paola ^a   Malfatti, Federica ^a   Chiarbonello, Bruno ^a   Mamone, Mario ^a   Savarino, Vincenzo ^a   Testa, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Cirrhosis; Cytochrome P 450; H pylori; Hepatitis C virus; Hepatocellular carcinoma; Liver

Indexed keywords

CYTOCHROME P450; DEETHYLLIDOCAINE; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENZYME ACTIVITY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037381698     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022861414826     Document Type: Article

References (50)

1. Marshall BJ: Helicobacter pylori. Am J Gastroenterol 89:S116-S128, 1994
2. Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ: Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 321:1562-1566, 1989
3. Tytgat GN: Helicobacter pylori: where are we and where are we going? Aliment Pharmacol Ther 14(suppl 3):55-58, 2000
4. Cremonini F, Gasbarrini A, Armuzzi A, Gasbarrini G: Helicobacter pylori-related diseases. Eur J Clin Invest 31:431-437, 2001
5. Gasbarrini A, Fox J, Gasbarrini G: Helicobacter pylori and other Helicobacter spp. Chronic infections and extragastric diseases. Eur J Gastroenterol Hepatol 12:1057-1060, 2000
6. Crabtree JE: Immune and inflammatory responses to Helicobacter pylori infection. Scand J Gastroenterol 31(suppl 215):3-10, 1996
7. Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Torte ES, et al: Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 45(suppl 1):I9-I12, 1999
8. Realdi G, Dore MP, Fastame L: Extradigestive manifestations of Helicobacter pylori infection. Fact and fiction. Dig Dis Sci 44:229-236, 1999
9. Balan KK, Jones AT, Roberts NB, Pearson JP, Critchley M, Jenkins SA: The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver. Am J Gastroenterol 91:1400-1406, 1996
10. Calvet X, Navarro M, Gil M, Mas P, Rivero E, Sanfeliu I, Brullet E, Campo R, Dalmau B, Lafont A: Seroprevalence and epidemiology of Helicobacter pylori infection in patients with cirrhosis. J Hepatol 26:1249-1254, 1997
11. Siringo S, Vaira D, Menegatti M, Piscaglia F, Sofia S, Gaetani M, Miglioli M, Corinaldesi R, Bolondi L: High prevalence of Helicobacter pylori in liver cirrhosis. Relationship with clinical and endoscopic features and the risk of peptic ulcer. Dig Dis Sci 42:2024-2030, 1997
12. Taylor-Robinson SD, Jackson N, Buckley C: Helicobacter pylori, ammonia and the brain. Gut 40:805-806, 1997
13. Calvet X, Navarro M, Gil M, Lafont, A, Sanfeliu I, Brullet E, Campo R, Dalmau B, Rivero E, Mas P: Epidemiology of peptic ulcer disease in cirrhotic patients: role of Helicobacter pylori infection. Am J Gastroenterol 93:2501-2507, 1998
14. Farinati F, De Bona M, Floreani A, Foschia F, Rugge M: Helicobacter and the liver: any relationship? Ital J Gastroenterol Hepatol 30:124-128, 1998
15. Pellicano R, Leone N, Berrutti M, Cutufia MA, Fiorentino M, Rizzetto M, Ponzetto A: Helicobacter pylori seroprevalence in hepatitis C virus postive patients with cirrhosis. J Hepatol 33:648-650, 2000
16. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ, Gorelick PL, Nagashima K, Gonda MA, Gilden RV: Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 86:1222-1227, 1994
17. Taylor NS, Fox JG, Yan L: In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol 42:48-52, 1995
18. Ponzetto A, Pellicano R, Leone N, Cutufia MA, Turrini F, Grigioni WF, D'Errico A, Mortimer P, Rizzetto M, Silengo L: Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 54:275-277, 2000
19. Avenaud P, Marais A, Monteiro L, Le Bail B, Bioulac Sage R Balabaud C, Megraud F: Detection of Helicobacter species in the liver of patients with and without primary liver cancer. Cancer 89:1431-1439, 2000
20. Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J: Tumor necrosis factor alpha and interleukin 6 plasma levels in infected cirrhotic patients. Gastroenterology 104:1492-1497, 1993
21. Quigley EMM: Gastrointestinal dysfuction in liver disease and portal hypertension. Gut-liver interactions revisited. Dig Dis Sci 41:557-563, 1996
22. Morgan ET: Regulation of cytochrome P450 by inflammatory mediators: why and how? Drug Metab Dispos 29:207-212, 2001
23. Cheng PY, Morgan ET: Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab 2:165-183, 2001
24. Tapner M, Liddle C, Goodwin B, George J, Farrell GC: Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology 24:367-373, 1996
25. Stadler J, Trockfeld J, Schmalix WA, Brill T, Siewert JR, Greim H, Doehmer J: Inhibition of cytochromes P4501A by nitric oxide. Proc Natl Acad Sci USA 91:3559-3563, 1994
26. Takemura S, Minamiyama Y, Imaoka S, Funae Y, Hirohashi K, Inoue M, Kinoshita H: Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia. J Hepatol 30:1035-1044, 1999
27. Giannini E, Fasoli A, Borro P, Chiarbonello B, Malfatti F, Romagnoli P, Botta F, Testa E, Fumagalli A, Polegato S, Savarino V, Testa R: Impairment of cytochrome P-450 dependent liver activity in cirrhotic patients with Helicobacter pylori infection. Aliment Pharmacol Ther 15:1975-1982, 2001
28. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R: Transection of the oesophagus for bleeding esophageal varices. Br J Surg 60:646-664, 1973
29. Shiffman ML, Luketic VA, Sanyal AJ, Duckworth PF, Purdum PP, Contos MJ, Mills AS, Edinboro LE, Poklis A: Hepatic lidocaine metabolism and liver histology in patients with chronic hepatitis and cirrhosis. Hepatology 19:933-940, 1994
30. Jalan R, Hayes PC: Review article: quantitative tests of liver function. Aliment Pharmacol Ther 9:263-270, 1995
31. Testa R, Caglieris S, Risso D, Arzani L, Campo N, Alvarez S, Giannini E, Lantieri PB, Celle G: Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease. Am J Gastroenterol 92:2268-2273, 1997
32. Oellerich M, Armstrong VW: The MEGX test: a tool for the real-time assessment of hepatic function. Ther Drug Monit 23:81-92, 2001
33. Durazzo M, Pellicano R, Premoli A, Berruti M, Leone N, Ponzetto A, Rizzetto M: Helicobacter pylori seroprevalence in patients with autoimmune hepatitis. Dig Dis Sci 47:380-383, 2002
34. Mégraud F: Advantages and disadvantages of current diagnostic tests for the detection of Helicobacter pylori. Scand J Gastroenterol 31(suppl 215):57-62, 1996
35. Xia HH, Talley NJ: Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol 92:1780-1787, 1997
36. Mc Cormick PA, Sankey EA, Cardin F, Dhillon AP, McIntyre N, Burroughs AK: Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study. Gut 32:351-354, 1991
37. Chen J-J, Changhchien C-S, Tai D-I, Chiou S-S, Lee C-M, Kuo C-H: Role of Helicobacter pylori in cirrhotic patients with peptic ulcer. A serological study. Dig Dis Sci 39:1565-1568, 1994
38. Calvet X, Nogueras C, Roqué M, Sanfeliu I: Is Helicobacter pylori a risk factor for hepatic encephalopathy? Dig Liver Dis 33:414-420, 2001
39. Ponzetto A, Fagoonee S, Pellicano R: Helicobacter pylori and liver: an actor with three roles? Dig Liver Dis 33:399-401, 2001
40. Figura N: Hypothesis: Helicobacter toxins and the liver. Helicobacter 1:187-189, 1996
41. Francavilla A, Ierardi E, Francavilla R, Principi M, Gentile A, Margiotta M, Balzano T, Passaro S, Noviello F, Panella C, Pollice L: Immunohistochemical detection of Helicobacter pylori vacuolating cytotoxin in the hepatocytes of patients with isolated hypertransaminasaemia. Ital J Gastroenterol Hepatol 31:669-674, 1999
42. Graham DY, Osato MS, Olson CA, Zhang J, Figura N: CagA, liver function, and leukocyte counts in duodenal ulcer patients. Gastroenterology 112:A3807, 1997
43. Francavilla A, Ierardi E: Helicobacter species in liver and biliary diseases. Dig Liver Dis 32(suppl 3):S217-S219, 2000
44. Bamford KB, Andersen L: Host response. Curr Opin Gastroenterol. 13(suppl 1):25-30, 1997
45. Perri F, Clemente F, Festa V, De Ambrosio CC, Quitadamo M, Fusillo M, Grossi E, Andriulli A: Serum tumor necrosis factor-alpha is increased in patients with Helicobacer pylori infection and CagA antibodies. Ital J Gastoenterol Hepatol 31:290-294, 1999
46. Renton KW, Knickle LC: Regulation of hepatic cytochrome P450 during infectious disease. Can J Physiol Pharmacol 68:777-781, 1990
47. Losser MR, Payen D: Mechanisms of liver damage. Semin Liver Dis 16:357-367, 1990
48. Bankey PE, Cerra FB. In Pathophysiology of Shock, Sepsis and Organ Failure. G Schlag, H Redl (eds). Berlin, Springer-Verlag, 1993. pp 948-957
49. Igonin AA, Armstrong VW, shipkova M, Kukes VG, Oellerich M: The monoethylglycinexylidide (MEGX) test as a marker of hepatic dysfunction in septic patients with pneumonia. Clin Chem Lab Med 38:1125-1128, 2000
50. Benhamou JP: What should the clinician know about the cytochrome P450 system? Eur J Gastroenterol Hepatol 12:415-417, 2000